|
1.
|
Smit W, Schouten N, van den Berg N,
Langedijk MJ, Struijk DG and Krediet RT; Netherlands
Ultrafiltration Failure Study Group: Analysis of the prevalence and
causes of ultrafiltration failure during long-term peritoneal
dialysis: a cross-sectional study. Perit Dial Int. 24:562–570.
2004.
|
|
2.
|
Kim YL: Update on mechanisms of
ultrafiltration failure. Perit Dial Int. 29(Suppl 2): S123–S127.
2009.PubMed/NCBI
|
|
3.
|
Selgas R, Bajo A, Jiménez-Heffernan JA,
Sánchez-Tomero JA, Del Peso G, Aguilera A and López-Cabrera M:
Epithelialto-mesenchymal transition of the mesothelial cell - its
role in the response of the peritoneum to dialysis. Nephrol Dial
Transplant. 21(Suppl 2): ii2–ii7. 2006.PubMed/NCBI
|
|
4.
|
Aroeira LS, Aguilera A, Sánchez-Tomero JA,
et al: Epithelial to mesenchymal transition and peritoneal membrane
failure in peritoneal dialysis patients: pathologic significance
and potential therapeutic interventions. J Am Soc Nephrol.
18:2004–2013. 2007. View Article : Google Scholar
|
|
5.
|
Elsurer R, Afsar B, Sezer S and Ozdemir
FN: Peritoneal cells at admission: do they have prognostic
significance in peritonitis? Ren Fail. 32:335–342. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Wienholds E, Kloosterman WP, Miska E, et
al: MicroRNA expression in zebrafish embryonic development.
Science. 309:310–311. 2005. View Article : Google Scholar
|
|
7.
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Kato M, Zhang J, Wang M, et al:
MicroRNA-192 in diabetic kidney glomeruli and its function in
TGF-beta-induced collagen expression via inhibition of E-box
repressors. Proc Natl Acad Sci USA. 104:3432–3437. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Ogawa T, Iizuka M, Sekiya Y, et al:
Suppression of type I collagen production by microRNA-29b in
cultured human stellate cells. Biochem Biophys Res Commun.
391:316–321. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Kong D, Li Y, Wang Z, et al: miR-200
regulates PDGF-D-mediated epithelial-mesenchymal transition,
adhesion, and invasion of prostate cancer cells. Stem Cells.
27:1712–1721. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Sabatel C, Cornet AM, Tabruyn SP, et al:
Sprouty1, a new target of the angiostatic agent 16K prolactin,
negatively regulates angiogenesis. Mol Cancer. 9:2312010.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Jeffrey SS: Cancer biomarker profiling
with microRNAs. Nat Biotechnol. 26:400–401. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Cortez MA, Bueso-Ramos C, Ferdin J, et al:
MicroRNAs in body fluids - the mix of hormones and biomarkers. Nat
Rev Clin Oncol. 8:467–477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Ge Y, Xiao L, Chen X, et al: MicroRNAs in
peritoneal dialysis effluent are promising biomarkers for
peritoneal fibrosis in peritoneal dialysis patients. Med
Hypotheses. 78:155–156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Wang B, Koh P, Winbanks C, et al: miR-200a
prevents renal fibrogenesis through repression of TGF-β2
expression. Diabetes. 60:280–287. 2011.PubMed/NCBI
|
|
16.
|
Yang S, Banerjee S, de Freitas A, et al:
Participation of miR-200 in pulmonary fibrosis. Am J Pathol.
180:484–493. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Iwano M, Plieth D, Danoff TM, et al:
Evidence that fibroblasts derive from epithelium during tissue
fibrosis. J Clin Invest. 110:341–350. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Williams JD, Craig KJ, Topley N and
Williams GT: Peritoneal dialysis: changes to the structure of the
peritoneal membrane and potential for biocompatible solutions.
Kidney Int Suppl. 84:S158–S161. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Williams JD, Craig KJ, Topley N, et al:
Peritoneal Biopsy Study Group: Morphologic changes in the
peritoneal membrane of patients with renal disease. J Am Soc
Nephrol. 13:470–479. 2002.PubMed/NCBI
|
|
20.
|
Yáñez-Mó M, Lara-Pezzi E, Selgas R, et al:
Peritoneal dialysis and epithelial-to-mesenchymal transition of
mesothelial cells. N Engl J Med. 348:403–413. 2003.
|
|
21.
|
Jiménez-Heffernan JA, Aguilera A, Aroeira
LS, et al: Immunohistochemical characterization of fibroblast
subpopulations in normal peritoneal tissue and in peritoneal
dialysis-induced fibrosis. Virchows Arch. 444:247–256. 2004.
|
|
22.
|
Schilte MN, Loureiro J, Keuning ED, ter
Wee PM, Celie JW, Beelen RH and van den Born J: Long-term
intervention with heparins in a rat model of peritoneal dialysis.
Perit Dial Int. 29:26–35. 2009.PubMed/NCBI
|
|
23.
|
Margetts PJ, Bonniaud P, Liu L, Hoff CM,
Holmes CJ, West-Mays JA and Kelly MM: Transient overexpression of
TGF-{beta}1 induces epithelial mesenchymal transition in the rodent
peritoneum. J Am Soc Nephrol. 16:425–436. 2005.
|
|
24.
|
Del Peso G, Jiménez-Heffernan JA, Bajo MA,
et al: Epithelial-to-mesenchymal transition of mesothelial cells is
an early event during peritoneal dialysis and is associated with
high peritoneal transport. Kidney Int Suppl. 108:S26–S33.
2008.PubMed/NCBI
|
